An increase in C-peptide levels in a young woman has drawn attention
Type 1 diabetes has long been considered an incurable condition. Patients diagnosed with it are typically told they will require lifelong insulin therapy and that the disease will progressively worsen.
However, recent clinical observations suggest that this may not fully apply to all cases.
Case
A 22-year-old woman in Azerbaijan was diagnosed with type 1 diabetes. Initial tests showed a C-peptide level of 0.26 ng/ml, indicating significantly reduced insulin production by the pancreas.
The initial prognosis suggested disease progression and increasing insulin dependency.
Further findings
Detailed investigations revealed:
- Possible chronic infection
- Recurrent purulent processes
- A damaged metal implant in the oral cavity
Treatment approach
A comprehensive integrative approach was applied:
- Elimination of infection sources
- Improvement of overall health condition
- Regulation of immune balance
Results
Over time:
- C-peptide levels increased to 1.12 ng/ml
- Later stabilized at approximately 0.6
Importantly, the levels did not drop to zero over a 3-year period.
Conclusion
Experts emphasize that this does not mean a cure for type 1 diabetes. However, it may indicate that in some patients, residual pancreatic function can be preserved or partially restored.
These findings highlight the importance of individualized treatment approaches and the need for further clinical research.
